Literature DB >> 28347943

The association between sodium fluctuations and mortality in surgical patients requiring intensive care.

Dominic C Marshall1, Justin D Salciccioli2, Ross J Goodson3, Marco A Pimentel4, Kristi Y Sun3, Leo Anthony Celi5, Joseph Shalhoub6.   

Abstract

PURPOSE: Serum sodium derangement is the most common electrolyte disturbance among patients admitted to intensive care. This study aims to validate the association between dysnatremia and serum sodium fluctuation with mortality in surgical intensive care patients.
METHOD: We performed a retrospective analysis of the Medical Information Mart for Intensive Care II database. Dysnatremia was defined as a sodium concentration outside physiologic range (135-145mmol/L) and subjects were categorized by severity of dysnatremia and sodium fluctuation. Univariate and multivariable logistic regressions were used to test for associations between sodium fluctuations and mortality.
RESULTS: We identified 8600 subjects, 39% of whom were female, with a median age of 66years for analysis. Subjects with dysnatremia were more likely to be dead at 28 days (17% vs 7%; P<.001). There was a significant association between sodium fluctuation and mortality at 28 days (adjusted odds ratio per 1mmol/L change, 1.10 [95% confidence interval, 1.08-1.12; P<.001]), even in patients who remained normotremic during their intensive care unit stay (1.12 [95% confidence interval, 1.09-1.16; P<.001])
CONCLUSIONS: This observational study validates previous findings of an association between serum sodium fluctuations and mortality in surgical intensive care patients. This association was also present in subjects who remained normonatremic throughout their intensive care unit admission.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Dysnatremia; Electrolyte disturbances; Mortality; Sodium; Surgery

Mesh:

Substances:

Year:  2017        PMID: 28347943      PMCID: PMC5679219          DOI: 10.1016/j.jcrc.2017.02.012

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  29 in total

Review 1.  Disorders of plasma sodium--causes, consequences, and correction.

Authors:  Richard H Sterns
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

Review 2.  The challenge of hyponatremia.

Authors:  Horacio J Adrogué; Nicolaos E Madias
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

3.  Hypernatremia in the intensive care unit: an indicator of quality of care?

Authors:  K H Polderman; W O Schreuder; R J Strack van Schijndel; L G Thijs
Journal:  Crit Care Med       Date:  1999-06       Impact factor: 7.598

Review 4.  Current concepts. Serum osmolality. Uses and limitations.

Authors:  F J Gennari
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

5.  [Incidence, causes and prognostic factors of hyponatremia in intensive care].

Authors:  S-L Bennani; R Abouqal; A-A Zeggwagh; N Madani; K Abidi; A Zekraoui; O Kerkeb
Journal:  Rev Med Interne       Date:  2003-04       Impact factor: 0.728

6.  Predictive factors for high mortality in hypernatremic patients.

Authors:  A K Mandal; M G Saklayen; N M Hillman; R J Markert
Journal:  Am J Emerg Med       Date:  1997-03       Impact factor: 2.469

7.  Incidence and prognosis of dysnatremias present on ICU admission.

Authors:  Georg-Christian Funk; Gregor Lindner; Wilfred Druml; Barbara Metnitz; Christoph Schwarz; Peter Bauer; Philipp G H Metnitz
Journal:  Intensive Care Med       Date:  2009-10-22       Impact factor: 17.440

8.  Hypernatremia in the critically ill is an independent risk factor for mortality.

Authors:  Gregor Lindner; Georg-Christian Funk; Christoph Schwarz; Nikolaus Kneidinger; Alexandra Kaider; Bruno Schneeweiss; Ludwig Kramer; Wilfred Druml
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

9.  Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients.

Authors:  Yasser Sakr; Steffen Rother; Alberto Mendonca Pires Ferreira; Christian Ewald; Pedro Dünisch; Niels Riedemmann; Konrad Reinhart
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

10.  Intensive care-acquired hypernatremia after major cardiothoracic surgery is associated with increased mortality.

Authors:  Gregor Lindner; Georg-Christian Funk; Andrea Lassnigg; Mohamed Mouhieddine; Salem-Ahmed Ahmad; Christoph Schwarz; Michael Hiesmayr
Journal:  Intensive Care Med       Date:  2010-07-24       Impact factor: 17.440

View more
  6 in total

1.  Trajectories of Serum Sodium on In-Hospital and 1-Year Survival among Hospitalized Patients.

Authors:  Api Chewcharat; Charat Thongprayoon; Wisit Cheungpasitporn; Michael A Mao; Sorkko Thirunavukkarasu; Kianoush B Kashani
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-25       Impact factor: 8.237

2.  Multivariable analysis of the association between electrolyte disturbances and mortality in cats.

Authors:  Robert Goggs; Sage De Rosa; Daniel J Fletcher
Journal:  J Feline Med Surg       Date:  2017-12-05       Impact factor: 2.015

3.  A deep learning backcasting approach to the electrolyte, metabolite, and acid-base parameters that predict risk in ICU patients.

Authors:  Albion Dervishi
Journal:  PLoS One       Date:  2020-12-17       Impact factor: 3.240

4.  Increased mortality risk associated with serum sodium variations and borderline hypo- and hypernatremia in hospitalized adults.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; John Q Yap; Qi Qian
Journal:  Nephrol Dial Transplant       Date:  2020-10-01       Impact factor: 5.992

5.  Electrolyte Disturbances Are Associated with Non-Survival in Dogs-A Multivariable Analysis.

Authors:  Robert Goggs; Sage De Rosa; Daniel J Fletcher
Journal:  Front Vet Sci       Date:  2017-08-18

6.  Serum sodium variability and acute kidney injury: a retrospective observational cohort study on a hospitalized population.

Authors:  Gianmarco Lombardi; Pietro Manuel Ferraro; Alessandro Naticchia; Giovanni Gambaro
Journal:  Intern Emerg Med       Date:  2020-08-09       Impact factor: 3.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.